Inventor · disambiguated record
Roger Schibli
Also filed as: SCHIBLI ROGER
23 granted patents·17 pending applications·202 citations·filing 1998–2024
95Inventor score
Top patents by PatentIndex Score
40 records- 0197US9717803B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2012·Granted Aug 1, 2017·29 cites·40 claims
- 0296US10675359B2Enzymatic conjugation of antibodiesINNATE PHARMA·Filed 2017·Granted Jun 9, 2020·11 cites·24 claims
- 0396US9764038B2Enzymatic conjugation of antibodiesINNATE PHARMA·Filed 2012·Granted Sep 19, 2017·38 cites·13 claims
- 0494US10434180B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2016·Granted Oct 8, 2019·20 cites·13 claims
- 0594US9427478B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2014·Granted Aug 30, 2016·30 cites·21 claims
- 0686US10130724B2Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatmentSCHERRER INST PAUL·Filed 2014·Granted Nov 20, 2018·4 cites·9 claims
- 0786US7053242B1Carbon monoxide source for preparation of transition-metal-carbonyl-complexesMALLINCKRODT INC·Filed 2000·Granted May 30, 2006·17 cites·25 claims
- 0882US7188725B2Kits for preparing transition metal carbonyl complexesMALLINCKRODT INC·Filed 2005·Granted Mar 13, 2007·4 cites·20 claims
- 0981US11396649B2Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase MTG and MTG in solutionSCHERRER INST PAUL·Filed 2017·Granted Jul 26, 2022·2 cites·23 claims
- 1078US10132799B2Screening of conjugated antibodiesINNATE PHARMA·Filed 2013·Granted Nov 20, 2018·3 cites·22 claims
- 1177US2025161479A1Transglutaminase conjugation method and linkerSCHERRER INST PAUL·Filed 2024·Application pending·0 cites
- 1276US9265746B2Method for cell-specific targetingMOSER RUDOLF·Filed 2006·Granted Feb 23, 2016·1 cites·33 claims
- 1376US2024279634A1Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase mtg and mtg in solutionSCHERRER INST PAUL·Filed 2024·Application pending·0 cites
- 1475US2024350656A1Transglutaminase conjugation method and linkerSCHERRER INST PAUL·Filed 2024·Application pending·0 cites
- 1572US11623014B2Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatmentSCHERRER INST PAUL·Filed 2020·Granted Apr 11, 2023·0 cites·14 claims
- 1672US6344178B1Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substratesMALLINCKRODT INC·Filed 1998·Granted Feb 5, 2002·39 cites·17 claims
- 1767US11629201B2PSMA-binding agents and uses thereofITM ISOTOPE TECH MUNICH SE·Filed 2018·Granted Apr 18, 2023·1 cites·61 claims
- 1867US10953114B2Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatmentSCHERRER INST PAUL·Filed 2018·Granted Mar 23, 2021·0 cites·12 claims
- 1967US9295739B2Folate conjugates of albumin-binding entitiesSCHIBLI ROGER·Filed 2012·Granted Mar 29, 2016·3 cites·40 claims
- 2066US2022333093A1Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase mtg and mtg in solutionSCHERRER INST PAUL·Filed 2022·Application pending·0 cites
- 2165US12128110B2Transglutaminase conjugation method and linkerSCHERRER INST PAUL·Filed 2018·Granted Oct 29, 2024·0 cites·31 claims
- 2262US10973936B218F-saccharide-folatesMerck & Cie·Filed 2019·Granted Apr 13, 2021·0 cites·20 claims
- 2361US2025127938A1Theragnostic folate conjugatesMERCK PATENT GMBH·Filed 2023·Application pending·0 cites
- 2459US2025108138A1Theragnostic folate conjugatesMERCK PATENT GMBH·Filed 2023·Application pending·0 cites
- 2557US2018071402A1Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2017·Application pending·0 cites
- 2654US12023390B2Isomerically pure 18F-labelled tetrahydrofolatesMERCK PATENT GMBH·Filed 2018·Granted Jul 2, 2024·0 cites·15 claims
- 2754US2025345469A1Composition comprising a rapalog and a radiolabelled gastrin analogue, in particular for use in the treatment and/or diagnosis of cckb receptor positive cancer or tumorsSCHERRER INST PAUL·Filed 2021·Application pending·0 cites
- 2854US2011286921A118f-labelled folates as pet radiotracersSCHIBLI ROGER·Filed 2009·Application pending·0 cites
- 2953US2024245811A1Alpha radiolabeled gastrin analogue and use thereof in methods of treating cckb receptor positive diseasesSCHERRER INST PAUL·Filed 2021·Application pending·0 cites
- 3052US2007184537A1Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptidesSCHERRER INST PAUL·Filed 2004·Application pending·0 cites
- 3151US10961246B218F-labelled folates as PET radiotracersMerck & Cie·Filed 2017·Granted Mar 30, 2021·0 cites·20 claims
- 3251US2017128599A1Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapyMerck & Cie·Filed 2016·Application pending·0 cites
- 3351US2009176968A1Preparation of Triazole Containing Metal Chelating AgentsSCHERRER INST PAUL·Filed 2007·Application pending·0 cites
- 3450US2010143249A1Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapyMERCK EPROVA AG·Filed 2008·Application pending·0 cites
- 3549US10322195B218F-saccharide-folatesSCHIBLI ROGER·Filed 2012·Granted Jun 18, 2019·0 cites·13 claims
- 3646US11649268B2Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapyETH ZUERICH·Filed 2017·Granted May 16, 2023·0 cites·16 claims
- 3744US2022133904A1Transglutaminase conjugation method with a glycine based linkerSCHERRER INST PAUL·Filed 2020·Application pending·0 cites
- 3841US2021361735A1Minigastrin derivates, in particular for use in cck2 receptor positive tumour diagnosis and/or treatmentSCHERRER INST PAUL·Filed 2018·Application pending·0 cites
- 3939US10357576B218F-labelled folate/antifolate analoguesMerck & Cie·Filed 2013·Granted Jul 23, 2019·0 cites·13 claims
- 4038US2022024882A1Novel tumor antigen binding agents and uses thereofITM ISOTOPEN TECH MUENCHEN AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roger Schibli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →